Bonus BioGroup Ltd
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of… Read more
Market Cap & Net Worth: Bonus BioGroup Ltd (BBIXF)
Bonus BioGroup Ltd (PINK:BBIXF) has a market capitalization of $35.04 Million ($35.04 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #28368 globally and #9463 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bonus BioGroup Ltd's stock price $0.03 by its total outstanding shares 1167925311 (1.17 Billion).
Bonus BioGroup Ltd Market Cap History: 2019 to 2025
Bonus BioGroup Ltd's market capitalization history from 2019 to 2025. Data shows change from $150.20 Million to $35.04 Million (-22.60% CAGR).
Bonus BioGroup Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bonus BioGroup Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BBIXF by Market Capitalization
Companies near Bonus BioGroup Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Bonus BioGroup Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Bonus BioGroup Ltd Historical Marketcap From 2019 to 2025
Between 2019 and today, Bonus BioGroup Ltd's market cap moved from $150.20 Million to $ 35.04 Million, with a yearly change of -22.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $35.04 Million | +50.00% |
| 2024 | $23.36 Million | 0.00% |
| 2023 | $23.36 Million | -60.00% |
| 2022 | $58.40 Million | -86.67% |
| 2021 | $437.97 Million | +316.67% |
| 2020 | $105.11 Million | -30.02% |
| 2019 | $150.20 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bonus BioGroup Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $35.04 Million USD |
| MoneyControl | $35.04 Million USD |
| MarketWatch | $35.04 Million USD |
| marketcap.company | $35.04 Million USD |
| Reuters | $35.04 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.